Layanan Telemedicine Terintegratif Dokter dan Apoteker bagi Penderita Covid-19 di Lingkungan Paroki Kristus Raja Surabaya
DOI:
https://doi.org/10.36565/jak.v4i3.388Keywords:
Covid-19, doctor-pharmacist, health services, telemedicineAbstract
The global pandemic related to the coronavirus (2019-nCoV) continues to hit the world, including Indonesia until the end of 2021. The efforts to improve health services were carried out by various parties, including by members of the King of Christ Parish church as part of the Surabaya community. From this parish in July 2021, 301 people were sick with COVID-19 and almost 11% of them died. The public and health services were panicked by the occurrence of a wave of viral mutations, with the increasing of sufferers and high mortality rates. Integrated telemedicine services between doctors and pharmacists are one of the best options to prevent transmission and severity to support patient recovery rates. With telemedicine, health care needs are individualized and patient development is more controlled. The method was carried out through direct consultation between doctors, pharmacist, and patients, using the whatsapp call platform. Monitoring of patients was continued by pharmacist using the whatsapp message platform until the patient was cured. If necessary, consultation with the doctor could be carried out again during the patient’s healing process. The research show that there is an integration of doctor and pharmacist services in telemedicine for COVID-19 patients in diagnosing, determining the best supporting drugs and therapies for the patients. Quantitatively, there was a decrease in the mortality rate, an increase in patient compliance and recovery. As an additional indicator, the residents welcome the integrated services that are carried out and can be developed for other health services.
References
Singhal Tanu. A review of coronavirus disease-2019 (Covid-19). Indian J Pediatr. 87, 281-286 (2020).
Wu, Yi-Chi Chen, Ching-Sung Chan, Yu-Jiun. The outbreak of Covid-19: An overview. Journal of the Chinese Medical Association. 83, 217-220 (2019).
Cascella Mario, Michael Rajnik, Abdul Aleem, Scott C. Dulebohn, Raffaela Di Napoli. Features, evaluation and treatment of coronavirus (Covid-19) (StatPearls Publishing, 2021).
Barati Fatamih, Mahdi Pouresmaieli, Elena Ekrami, Sahar Asghari, Farzad Ramezani Ziarani, Matin Mamoudifard. Potential drug and remedies for the treatment of COVID-19: a critical review. Biol Proceed online 22:15 (2020).
BPOM RI. Informatorium obat Covid-19 di Indonesia (BPOM RI. Jakarta, 2020).
Joyce, Emer., Fabre, Aurelie., Mahon, Niall.. Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literatur review. Eur Heart J Acute Cardiovasc Care. 2, 77–83 (2013).
Andrew Bryan, Lawrie, Theresa A., Dowswell, Therese, Fordham, Edmund J., Mitchell, Scott; Hill, Sarah, Tham, Tony C. Ivermectin for prevention and treatment of COVID-19 infection: A systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. American Journal of Therapeutics. 28 (2021).
Pasaribu Karl Frizts, Dedy Arisjulyanto, Baiq Tiara Hikmatushaliha. Pengembangan telemedicine dalam mengatasi konektivitas dan aksesibilitas pelayanan kesehatan, Berita Kedokteran Masyarakat. 34 (2018).
Bayu, M., Sampurno, T., Mada, U. G., Kusumandyoko, T., Surabaya, U. N., Islam, M. A., Surabaya, U. N., & Branding, V. Budaya media sosial , edukasi masyarakat , dan pandemi COVID-19. SALAM Jurnal Sosial dan Budaya Syar I. (2020).
Agung, I. M.. Memahami pandemi COVID-19 dalam perspektif psikologi sosial. Psikobuletin: Buletin Ilmiah Psikologi, 1, 68–84 (2020).
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).